Japan Mechanical Circulatory Support (MCS) Device Market was valued at USD 0.4 Billion in 2022 and is projected to reach USD 0.9 Billion by 2030, growing at a CAGR of 10.6% from 2024 to 2030.
Japan's Mechanical Circulatory Support (MCS) device market has experienced significant growth, driven by technological advancements and an increasing prevalence of heart failure. Understanding the types of MCS devices and the specific requirements from industries is essential for stakeholders aiming to navigate this evolving landscape effectively.
Types of Mechanical Circulatory Support Devices in Japan
Extracorporeal Membrane Oxygenation (ECMO): ECMO provides temporary support for patients with severe cardiac or respiratory failure. In Japan, over 7,000 patients annually have benefited from peripheral ECMO, underscoring its critical role in acute care settings.
Intra-Aortic Balloon Pump (IABP): IABP remains the most commonly used MCS device in elective percutaneous coronary interventions (PCI) across Japan, accounting for approximately 86% of cases. Its widespread adoption is attributed to its ease of use and established efficacy.
Ventricular Assist Devices (VADs): VADs, including implantable left ventricular assist devices (LVADs), offer long-term support for patients with advanced heart failure. Japan has seen over 1,200 continuous-flow LVAD implantations in the past decade, achieving a remarkable 91% two-year survival rate. Notably, more than 70% of heart transplant recipients required LVAD support for over three years, highlighting the device's importance in bridging patients to transplantation.
Impella Devices: The Impella, a percutaneous microaxial blood pump, has been utilized in over 4,000 patients in Japan over the past four years. It offers less invasive support compared to traditional methods, providing short-term assistance during high-risk PCI procedures.
Industry Requirements and Considerations
Regulatory Compliance: Manufacturers must navigate Japan's stringent approval processes. For instance, the Impella received approval from the Pharmaceuticals and Medical Devices Agency (PMDA) in September 2016, emphasizing the need for rigorous clinical evaluations to meet regulatory standards.
Technological Innovation: The development of novel devices, such as a centrifugal pump with a hydrodynamically levitated impeller, showcases Japan's commitment to advancing MCS technology. Continuous innovation is vital to address the diverse needs of heart failure patients effectively.
Post-Market Surveillance: Participation in registries like the Japanese registry for Mechanically Assisted Circulatory Support (J-MACS) is mandatory. From June 2010 to April 2015, 476 patients were registered across 31 hospitals, providing valuable data on patient demographics, device types, survival rates, and adverse events. This information is crucial for ongoing device evaluation and improvement.
Clinical Training and Support: Ensuring that healthcare professionals are adequately trained in the use of MCS devices is essential. Proper training minimizes complications and enhances patient outcomes, thereby increasing the adoption and success of these technologies.
Patient-Centric Design: Devices that prioritize patient comfort and quality of life are more likely to be accepted. For example, the development of smaller, more efficient VADs aims to reduce the physical burden on patients, facilitating mobility and daily activities.
In conclusion, Japan's MCS device market is characterized by a diverse range of technologies tailored to meet the varying needs of heart failure patients. Industries involved in this sector must focus on regulatory adherence, technological advancement, comprehensive post-market surveillance, robust clinical training programs, and patient-centered design to thrive in this dynamic environment. Notably, the evolution of the 100 Gigabit Fiber Optic Transceiver Market Type and requirements from industries offers valuable insights into how technological innovation and industry collaboration can drive growth and improve outcomes in the MCS device market.
Get an In-Depth Research Analysis of the Japan Mechanical Circulatory Support (MCS) Device Market Size And Forecast [2025-2032]
Â
AbioMed
Abbott
Medtronic
Berlin Heart
Jarvik Heart
Sun Medical Technology Research
BiVACOR
SynCardia
CARMAT
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Mechanical Circulatory Support (MCS) Device Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Mechanical Circulatory Support (MCS) Device Market
Ventricular Assist Devices (VADs)
Total Artificial Heart (TAH)
Intra-Aortic Balloon Pump (IABP)
Other Mechanical Circulatory Support Devices
Pulsatile Flow Devices
Non-Pulsatile Flow Devices
Implantable Devices
Extracorporeal Devices
Bridge to Transplantation
Bridge to Recovery
Destination Therapy
Bridge to Decision
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Other Healthcare Facilities
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Japan Mechanical Circulatory Support (MCS) Device Market Research Analysis
1. Introduction of the Japan Mechanical Circulatory Support (MCS) Device Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Mechanical Circulatory Support (MCS) Device Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Mechanical Circulatory Support (MCS) Device Market, By Type
6. Japan Mechanical Circulatory Support (MCS) Device Market, By Application
7. Japan Mechanical Circulatory Support (MCS) Device Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. Japan Mechanical Circulatory Support (MCS) Device Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/